3 years ago
VIR
AnalystsJoseph StringerJoseph Stringer's Stock Forecasts
AnalystsJoseph Stringer
Sectors:
Industries:
Analyst Ranking
Top 3%
#133 out of 5000 analysts
Average Return
+14.99%
Win Rate
45%137 out of 304
Risk vs Reward
Poor
Good
Joseph Stringer's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +454.80% | $7.81 | $43.33 | 2023-11-29 - 2024-11-27 | Buy |
Cidara Therapeutics IncCDTX | +391.84% | $12.86 | $63.25 | 2024-08-14 - 2025-08-13 | Buy |
Rhythm Pharmaceuticals IncRYTM | +367.51% | $3.94 | $18.42 | 2022-06-17 - 2023-06-16 | Buy |
Inozyme Pharma IncINZY | +361.99% | $0.86 | $3.95 | 2025-04-08 - 2025-05-16 | Buy |
Avidity Biosciences IncRNA | +347.81% | $9.35 | $41.87 | 2023-08-09 - 2024-08-08 | Buy |
Joseph Stringer Analyst Color
Get additional color on Joseph Stringer's coverage of popular stocks
Joseph Stringer's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ionis Pharmaceuticals IncIONS | 22 | Buy | $55.00 | +29.05% | Reiterates | 5 days ago |
Cidara Therapeutics IncCDTX | 13 | Buy | $74.00 | +13.44% | Maintains | 22 days ago |
Alnylam Pharmaceuticals IncALNY | 23 | Buy | $478.00 | +5.68% | Maintains | a month ago |
Gilead Sciences IncGILD | 1 | Buy | $133.00 | +18.16% | Upgrades | a month ago |
Rhythm Pharmaceuticals IncRYTM | 25 | Buy | $95.00 | -8.86% | Maintains | 2 months ago |
Stoke Therapeutics IncSTOK | 21 | Buy | $22.00 | +11.28% | Reiterates | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 51 | Buy | $28.00 | +126.54% | Maintains | 3 months ago |
Vir Biotechnology IncVIR | 18 | Buy | $14.00 | +177.78% | Reiterates | 3 months ago |
Inozyme Pharma IncINZY | 20 | Hold | $12.00 | +200.00% | Downgrades | 3 months ago |
Annexon IncANNX | 17 | Buy | $11.00 | +418.87% | Maintains | 4 months ago |
Apellis Pharmaceuticals IncAPLS | 19 | Buy | $29.00 | +3.39% | Maintains | 4 months ago |
Avidity Biosciences IncRNA | 17 | Buy | $60.00 | +23.51% | Reiterates | 5 months ago |
Vaxcyte IncPCVX | 17 | Buy | $90.00 | +192.49% | Reiterates | 5 months ago |
Pliant Therapeutics IncPLRX | 17 | Hold | $10.00 | +517.28% | Downgrades | 6 months ago |
Tvardi Therapeutics IncTVRD | 14 | Buy | $60.00 | N/A | Reiterates | a year ago |
Acadia Pharmaceuticals IncACAD | 4 | Buy | $37.00 | N/A | Upgrades | 2 years ago |
Intercept Pharmaceuticals IncICPT | 4 | Buy | $26.00 | N/A | Maintains | 2 years ago |
Zealand Pharma AZEAL | 1 | Buy | $32.00 | N/A | Maintains | 3 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Theravance Biopharma IncTBPH | 2 | Buy | $18.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.